Skip to content

Clinical trials

Phase 3 Kidney Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Kidney Neoplasms Phase: Phase 3 Country / region: United States Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20032
20041
20051
20061
20072
20084
20091
20112
20122
20161
20173
20181
20191
20201
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Terminated4
Active, not recruiting3
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer6
Heidelberg Pharma AG3
Agenus Inc.2
Alliance for Clinical Trials in Oncology2
Children's Oncology Group2
Arcus Biosciences, Inc.1
Argos Therapeutics1
AstraZeneca1
Bristol-Myers Squibb1
Dan Zandberg1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Kidney Neoplasms30
Carcinoma, Renal Cell21
Neoplasms3
Wilms Tumor3
Kidney Diseases2
Melanoma2
Anus Neoplasms1
Burkitt Lymphoma1
Carcinoma1
Carcinoma, Hepatocellular1

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.